Matthew G Oser

14PUBLICATIONS
134CO-AUTHORS
Predictive and prognostic markersMolecular targetsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 17, 2026
Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung Cancer.

|Aug 20, 2025
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors.

Shilpa Singh, Catherine E Gleason, Min Fang

|Jul 17, 2025
EED Maintains the Small Cell Lung Cancer Neuroendocrine Phenotype and Drives Lung Cancer Histological Transformation.

Yixiang Li, Yasmin N Laimon, Hyeonseo Cho

|Jun 11, 2025
Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report.

Eleonora Gariazzo, Sanna Laaksonen, Stephanie Canty

|Apr 29, 2025
The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study Comparisons of the Transcriptomic Landscapes Across Mouse Models.

Ling Cai, Fangjiang Wu, Qinbo Zhou

|Aug 30, 2024
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F Activity.

Shilpa Singh, Catherine E Gleason, Min Fang

Pageof 3

Frequent Collaborators

6 joint publications

Henry W Long

6 joint publications

Xintao Qiu

4 joint publications

Rong Li

4 joint publications

Matthew L Freedman